Clinical Usefulness of a Database Predicting Drug-Drug Interactions Using Metabolic Information for Cytochrome P-450, as Evaluated From Dosage and Adverse Events of HMG-CoA Reductase Inhibitor Atorvastatin

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
doi 10.5649/jjphcs.32.1204
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Pharmaceutical Health Care and Sciences

Related search

Cytochrome P-450 and Drug Oxidation

Biochemical Journal
1969English

Clinical Pharmacology. Adverse Drug Interactions.

BMJ
1981English

Effects of Combined Therapy Using HMG-CoA Reductase Inhibitor and Colestimide on Refractory Hypercholesterolemia

The Journal of Japan Atherosclerosis Society
2002English

Usefulness of the Liverpool Adverse Events Profile for Predicting a High Risk of Suicidality in People With Drug-Resistant Epilepsy

Seizure : the journal of the British Epilepsy Association
MedicineNeurology
2019English

The HMG-CoA Reductase Inhibitor Atorvastatin Increases the Fractional Clearance Rate of Postprandial Triglyceride-Rich Lipoproteins in Miniature Pigs

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
1998English

Drug–drug–gene Interactions and Adverse Drug Reactions

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2019English

Carotid Intimal-Media Thickness as a Surrogate for Cardiovascular Disease Events in Trials of HMG-CoA Reductase Inhibitors

Current Controlled Trials in Cardiovascular Medicine
2005English

Effects of Lead on Drug Metabolizing Enzymes, Cytochrome P-450 and Hemeoxygenase in Rats.

Sangyo Igaku
1990English

Atorvastatin-Induced Lichenoid Drug Eruption: A Case Report and Review of Statin-Associated Cutaneous Adverse Events

Cureus
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy